C E Herzog
Overview
Explore the profile of C E Herzog including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
22
Citations
328
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Phadnis S, Wang X, Daw N, Herzog C, Subbiah I, Zaky W, et al.
ESMO Open
. 2023 Oct;
8(6):101609.
PMID: 37879233
Background: Combined use of inhibitors of mammalian target of rapamycin (mTOR) and vascular endothelial growth factor (VEGF-2) receptors is a potential strategy to overcome resistance to either class of drugs...
2.
Hayes-Jordan A, Lopez C, Green H, Xiao L, Huh W, Herzog C
Pediatr Surg Int
. 2015 Oct;
32(1):71-3.
PMID: 26500075
Purpose: Cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) have been used in adults with ovarian carcinoma proving overall survival benefit in randomized trials, but measured in months. Diffuse peritoneal...
3.
Bagatell R, Herzog C, Trippett T, Grippo J, Cirrincione-Dall G, Fox E, et al.
Clin Cancer Res
. 2010 Dec;
17(3):611-9.
PMID: 21127194
Purpose: This pediatric phase I study was designed to identify the doses of RG1507, a monoclonal antibody against the Type 1 Insulin-like Growth Factor Receptor (IGF1R), that achieves exposures equivalent...
4.
Wyatt A, Herzog C, Lazar A
Clin Exp Dermatol
. 2006 Oct;
32(1):123-4.
PMID: 17059446
No abstract available.
5.
Cormier J, Patel S, Herzog C, Ballo M, Burgess M, Feig B, et al.
Cancer
. 2001 Dec;
92(6):1550-5.
PMID: 11745234
Background: The current study was performed to evaluate the toxicity profile of therapeutic doses of ifosfamide (IFX) given concurrently with full-dose external beam radiotherapy (EBRT) in patients with soft tissue...
6.
Meyers P, Krailo M, Ladanyi M, Chan K, Sailer S, Dickman P, et al.
J Clin Oncol
. 2001 Jun;
19(11):2812-20.
PMID: 11387352
Purpose: To determine whether consolidation therapy with high-dose melphalan, etoposide, and total-body irradiation (TBI) with autologous stem-cell support would improve the prognosis for patients with newly diagnosed metastatic Ewing's sarcoma...
7.
Herzog C, Andrassy R, Eftekhari F
Oncologist
. 2000 Dec;
5(6):445-53.
PMID: 11110595
Hepatoblastoma is the most common primary liver tumor in children, accounting for just over 1% of pediatric cancers. The etiology is unknown, but it has been associated with Beckwith-Weidemann syndrome,...
8.
9.
Worth L, Slopis J, Herzog C
Med Pediatr Oncol
. 1999 Nov;
33(6):591-3.
PMID: 10573588
No abstract available.
10.
Brewer M, Gershenson D, Herzog C, Mitchell M, Silva E, Wharton J
J Clin Oncol
. 1999 Nov;
17(9):2670-75.
PMID: 10561340
Purpose: To review the outcome for all patients with ovarian dysgerminoma treated at the M.D. Anderson Cancer Center who received bleomycin, etoposide, and cisplatin (BEP) and to assess the menstrual...